Teladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Quantinno Capital Management LP

Quantinno Capital Management LP grew its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 78.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 331,731 shares of the health services provider's stock after purchasing an additional 145,588 shares during the period. Quantinno Capital Management LP owned approximately 0.19% of Teladoc Health worth $3,015,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of TDOC. Maple Rock Capital Partners Inc. increased its holdings in shares of Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after purchasing an additional 2,331,000 shares during the period. Vanguard Group Inc. grew its holdings in Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after acquiring an additional 1,029,829 shares during the period. Renaissance Technologies LLC grew its holdings in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after acquiring an additional 763,265 shares during the period. Nisa Investment Advisors LLC grew its holdings in Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after acquiring an additional 424,180 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after acquiring an additional 384,528 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Trading Down 2.8%

TDOC opened at $7.31 on Tuesday. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The stock has a market capitalization of $1.28 billion, a price-to-earnings ratio of -1.27 and a beta of 1.82. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The business has a fifty day moving average price of $7.55 and a 200 day moving average price of $9.35.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Sell-side analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Stifel Nicolaus dropped their target price on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Wells Fargo & Company decreased their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 8th. Royal Bank of Canada lifted their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Jefferies Financial Group reduced their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Finally, Oppenheimer reduced their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Teladoc Health currently has an average rating of "Hold" and an average target price of $9.71.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. The trade was a 14.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.58% of the stock is owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.